Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets

Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets

Alzheimer's disease (AD) is characterized by an accumulation of β-amyloid (Aβ42) accompanied by brain atrophy and cognitive decline. Several recent studies have shown that Aβ42 accumulation is associated with gray matter (GM) changes prior to the development of cognitive impairment, in the so-c...

Full description

Bibliographic Details
Main Authors:	Carles Falcon, Alan Tucholka, Gemma C. Monté-Rubio, Raffaele Cacciaglia, Grégory Operto, Lorena Rami, Juan Domingo Gispert, José Luis Molinuevo
Format:	Article
Language:	English
Published:	Elsevier 2018-01-01
Series:	NeuroImage: Clinical
Online Access:	http://www.sciencedirect.com/science/article/pii/S2213158218301256

Similar Items

CSF glial biomarkers YKL40 and sTREM2 are associated with longitudinal volume and diffusivity changes in cognitively unimpaired individuals
by: Carles Falcon, et al.
Published: (2019-01-01)

A whole-brain computational modeling approach to explain the alterations in resting-state functional connectivity during progression of Alzheimer's disease
by: Murat Demirtaş, et al.
Published: (2017-01-01)

Mechanisms of functional compensation, delineated by eigenvector centrality mapping, across the pathophysiological continuum of Alzheimer’s disease
by: Stavros Skouras, et al.
Published: (2019-01-01)

Prediction of amyloid pathology in cognitively unimpaired individuals using voxel-wise analysis of longitudinal structural brain MRI
by: Paula M. Petrone, et al.
Published: (2019-08-01)

APOE-ε4 risk variant for Alzheimer's disease modifies the association between cognitive performance and cerebral morphology in healthy middle-aged individuals
by: Raffaele Cacciaglia, et al.
Published: (2019-01-01)

Management and Quality Control of Large Neuroimaging Datasets: Developments From the Barcelonaβeta Brain Research Center
by: Jordi Huguet, et al.
Published: (2021-04-01)

Longitudinal study of CSF biomarkers in patients with Alzheimer's disease.
by: Peder Buchhave, et al.
Published: (2009-01-01)

Interactive effect of age and APOE-ε4 allele load on white matter myelin content in cognitively normal middle-aged subjects
by: Grégory Operto, et al.
Published: (2019-01-01)

Dynamic changes of CSF sTREM2 in preclinical Alzheimer’s disease: the CABLE study
by: Ling-Zhi Ma, et al.
Published: (2020-04-01)

Projection to Latent Spaces Disentangles Pathological Effects on Brain Morphology in the Asymptomatic Phase of Alzheimer's Disease
by: Adrià Casamitjana, et al.
Published: (2020-07-01)

Longitudinal brain atrophy and CSF biomarkers in early-onset Alzheimer’s disease
by: José Contador, et al.
Published: (2021-01-01)

White matter microstructure is altered in cognitively normal middle-aged APOE-ε4 homozygotes
by: Grégory Operto, et al.
Published: (2018-05-01)

Autosomal dominant Alzheimer disease: A unique resource to study CSF biomarker changes in preclinical AD
by: Suzanne Elizabeth Schindler, et al.
Published: (2015-06-01)

Association between insomnia and cognitive performance, gray matter volume, and white matter microstructure in cognitively unimpaired adults
by: Oriol Grau-Rivera, et al.
Published: (2020-01-01)

APOE ϵ4 Allele Is Associated with Elevated Levels of CSF VILIP-1 in Preclinical Alzheimer’s Disease
by: Wang L, et al.
Published: (2020-04-01)

Genetic Predisposition to Alzheimer’s Disease Is Associated with Enlargement of Perivascular Spaces in Centrum Semiovale Region
by: Iacopo Ciampa, et al.
Published: (2021-05-01)

Brain and cognitive correlates of subjective cognitive decline-plus features in a population-based cohort
by: Gonzalo Sánchez-Benavides, et al.
Published: (2018-12-01)

Concordance of CSF measures of Alzheimer's pathology with amyloid PET status in a preclinical cohort: A comparison of Lumipulse and established immunoassays
by: Ashvini Keshavan, et al.
Published: (2020-01-01)

Centiloid cut-off values for optimal agreement between PET and CSF core AD biomarkers
by: Gemma Salvadó, et al.
Published: (2019-03-01)

Chemokines in CSF of Alzheimer's disease patients
by: Jôice Dias Corrêa, et al.
Published: (2011-06-01)

CSF Biomarkers for Alzheimer's Disease Diagnosis
by: A. Anoop, et al.
Published: (2010-01-01)

Association of weight change with cerebrospinal fluid biomarkers and amyloid positron emission tomography in preclinical Alzheimer’s disease
by: Oriol Grau-Rivera, et al.
Published: (2021-02-01)

Cognitively unimpaired individuals with a low burden of Aβ pathology have a distinct CSF biomarker profile
by: Marta Milà-Alomà, et al.
Published: (2021-07-01)

Longitudinal evaluation of criteria for subjective cognitive decline and preclinical Alzheimer's disease in a memory clinic sample
by: Marie Eckerström, et al.
Published: (2017-01-01)

An Algorithm for Preclinical Diagnosis of Alzheimer's Disease
by: Tapan K. Khan
Published: (2018-04-01)

Spatial patterns of white matter hyperintensities associated with Alzheimer’s disease risk factors in a cognitively healthy middle-aged cohort
by: Gemma Salvadó, et al.
Published: (2019-01-01)

Current Biomarkers for Alzheimer’s Disease: From CSF to Blood
by: Kun Zou, et al.
Published: (2020-08-01)

Levels of ADAM10 are reduced in Alzheimer’s disease CSF
by: Aitana Sogorb-Esteve, et al.
Published: (2018-07-01)

Volume transmission of CSF: complications in aging and Alzheimer's disease
by: Duncan J, et al.
Published: (2004-12-01)

Exacerbated CSF abnormalities in younger patients with Alzheimer's disease
by: Julien Dumurgier, et al.
Published: (2013-06-01)

CSF p-Tau levels in the prediction of Alzheimer's disease
by: Ramesh J. L. Kandimalla, et al.
Published: (2013-09-01)

Perivascular spaces are associated with tau pathophysiology and synaptic dysfunction in early Alzheimer’s continuum
by: Natalia Vilor-Tejedor, et al.
Published: (2021-08-01)

CSF Proteomic Alzheimer’s Disease-Predictive Subtypes in Cognitively Intact Amyloid Negative Individuals
by: Betty Marije Tijms, et al.
Published: (2021-08-01)

Entorhinal and Transentorhinal Atrophy in Preclinical Alzheimer's Disease
by: Sue Kulason, et al.
Published: (2020-08-01)

Preclinical diagnosis of Alzheimer's disease: Prevention or prediction?
by: Ricardo Nitrini

Cerebrospinal fluid (CSF) 25-hydroxyvitamin D concentration and CSF acetylcholinesterase activity are reduced in patients with Alzheimer's disease.
by: Per Johansson, et al.
Published: (2013-01-01)

Inter-network connectivity and amyloid-beta linked to cognitive decline in preclinical Alzheimer’s disease: a longitudinal cohort study
by: Roy W. E. Van Hooren, et al.
Published: (2018-08-01)

Decision tree supports the interpretation of CSF biomarkers in Alzheimer's disease
by: Rosha Babapour Mofrad, et al.
Published: (2019-12-01)

Kynurenic Acid Levels are Increased in the CSF of Alzheimer’s Disease Patients
by: Marta González-Sánchez, et al.
Published: (2020-04-01)

CSF and brain structural imaging markers of the Alzheimer's pathological cascade.
by: Xianfeng Yang, et al.
Published: (2012-01-01)